13766.00GBp+0.13%Mkt Cap: 213.09B GBpP/E: 28.04Last update: 2026-05-13
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza,…
Industry Peers
Drug Manufacturers - Generalloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)28.04
P/E (Forward)15.72
PEG1.55
P/B6.06
P/S3.50
EV/EBITDA11.88
EV/Revenue3.93
EPS (TTM)4.91
EPS (Forward)8.67
Cash Flow & Leverage
FCF Yield3.07%
FCF Margin10.82%
Operating CF14.57B GBp
CapEx (TTM)5.91B GBp
Net Debt/EBITDA1.32
Net Debt26.35B GBp
Technical
SMA 5014314.56 (-3.8%)
SMA 20013450.03 (+2.3%)
Beta0.22
S&P 52W Chg24.23%
Avg Vol (30d)2.08M
Avg Vol (10d)2.34M
Technical Indicators
RSI (14)44.1
MACD-287.3900
MACD Signal-268.8104
MACD Hist.-18.5797
BB Upper15212.37 GBp
BB Middle14045.49 GBp
BB Lower12878.61 GBp
BB Width16.62%
ATR (14)372.17 GBp
Vol Ratio (20d)0.77x
52W Range
9932.0066% of range15732.00
52W High15732.00 GBp
52W Low9932.00 GBp
Profitability
Gross Margin81.90%
EBITDA Margin33.08%
Profit Margin17.41%
Oper. Margin28.17%
ROE21.01%
ROA8.96%
Revenue Growth12.50%
Earnings Growth5.30%
Balance Sheet
Debt/Equity0.60
Current Ratio0.91
Quick Ratio0.70
Book Value/Sh22.48 GBp
Cash/Share4.955 GBp
Dividends
Fwd Div Rate2.360 GBp
Trail. Div Rate3.200 GBp
Div. Yield1.73%
5Y Avg Yield2.10%
Payout Ratio47.70%
Ex-Div DateFeb 19, 2026
Pay Date—
Ownership
Shares Out.1.55B
Float1.54B
Insiders0.04%
Institutions61.24%
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)16643.28 GBp
Target Range11351.27 GBp – 18956.90 GBp
# Analysts21
Company
Market Cap213.09B GBp
Enterprise Value237.56B GBp
Revenue (TTM)60.44B GBp
Gross Profit48.11B GBp
Net Income (TTM)10.22B GBp
Revenue/Share39.00 GBp
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees96.1K
Last Price13766.00 GBp
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - General
ISINGB0009895292